These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20567964)

  • 21. [Osteoporosis in chronic obstructive pulmonary disease].
    Pobeha P; Lazúrová I; Tkácová R
    Vnitr Lek; 2010 Nov; 56(11):1142-9. PubMed ID: 21250492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
    van Staa TP
    Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.
    Oshagbemi OA; Burden AM; Shudofsky KN; Driessen JHM; Vestergaard P; Krings A; Franssen FME; van den Bergh J; de Vries F
    Bone; 2018 May; 110():238-243. PubMed ID: 29462672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P; Gonzalez AV; Brassard P; Suissa S
    Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment.
    Zanini A; Chetta A; Saetta M; Baraldo S; Castagnetti C; Nicolini G; Neri M; Olivieri D
    Thorax; 2009 Dec; 64(12):1019-24. PubMed ID: 19736178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
    COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
    Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
    Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids.
    Vestergaard P; Rejnmark L; Mosekilde L
    Chest; 2007 Nov; 132(5):1599-607. PubMed ID: 17890464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?
    Maak CA; Tabas JA; McClintock DE
    J Emerg Med; 2011 Feb; 40(2):135-45. PubMed ID: 18572345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease.
    Carter JD; Patel S; Sultan FL; Thompson ZJ; Margaux H; Sterrett A; Carney G; Murphy N; Huang Y; Valeriano J; Vasey FB
    Respir Med; 2008 Aug; 102(8):1165-72. PubMed ID: 18562189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
    Penning-van Beest F; van Herk-Sukel M; Gale R; Lammers JW; Herings R
    Respir Med; 2011 Feb; 105(2):259-65. PubMed ID: 20705441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of osteoporosis in patients with COPD: a 3-year follow up study.
    Graat-Verboom L; Smeenk FW; van den Borne BE; Spruit MA; Jansen FH; van Enschot JW; Wouters EF
    Respir Med; 2012 Jun; 106(6):861-70. PubMed ID: 22369986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA; Weiss KB
    Am J Respir Crit Care Med; 2004 Apr; 169(7):855-9. PubMed ID: 14711795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease.
    Majumdar SR; Villa-Roel C; Lyons KJ; Rowe BH
    Respir Med; 2010 Feb; 104(2):260-6. PubMed ID: 19828305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants.
    de Jong WU; de Jong PA; Vliegenthart R; Isgum I; Lammers JW; Oudkerk M; van der Aalst C; de Koning HJ; Mohamed Hoesein FA
    J Bone Miner Res; 2014 Oct; 29(10):2224-9. PubMed ID: 24715549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled corticosteroids and fracture risk in COPD.
    Suissa S; Ernst P
    Am J Respir Crit Care Med; 2004 Jul; 170(1):94; author reply 94-5. PubMed ID: 15220123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.